Connect Biopharma Holdings CNTB
NASDAQ CNTB
$2.06 +0.05 (+2.50%)
As of: Sep 10, 2026 · 3:59 PM EDT

Connect Biopharma Holdings (CNTB) Treasury Shares (2020 - 2026)

Connect Biopharma Holdings' (CNTB) quarterly Treasury Shares came in at $180000.0 in Q2 2026, little changed year-over-year from $180000.0 in Q2 2025, and little changed quarter-over-quarter from $180000.0 in Q1 2026.

Analysis

Connect Biopharma Holdings (CNTB) Treasury Shares (2020 - 2026) Analysis & Trends

Connect Biopharma Holdings has disclosed Treasury Shares across 7 years of filings, most recently posting $180000.0 for Q2 2026.

  • In Q2 2026, Treasury Shares changed 0.0% year-over-year to $180000.0; the TTM figure through Jun 2026 stood at $180000.0 (changed 0.0% YoY), while the FY2025 annual figure was $180000.0, changed 0.0% from the prior year.
  • Treasury Shares came in at $180000.0 for Q2 2026 at Connect Biopharma Holdings, roughly flat from $180000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.5 million in Q4 2024 to a low of $2.1 million in Q4 2025.
  • Average Treasury Shares over 3 years is $2.4 million, with a median of $2.4 million recorded in 2023.
  • Year-over-year, Treasury Shares declined 10.11% in 2022 and rose 11.8% in 2024.
  • Over 5 years, Treasury Shares stood at $163663.1 in 2022, then grew by 9.98% to $180000.0 in 2023, then changed by 0.0% to $180000.0 in 2024, then changed by 0.0% to $180000.0 in 2025, then changed by 0.0% to $180000.0 in 2026.
  • Per Business Quant data, the three most recent Treasury Shares figures were $180000.0 in Q2 2026, $180000.0 in Q1 2026, and $180000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 36.40 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -23.80 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Connect Biopharma Holdings 129.86 Mn 129.86 Mn - 180,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 180,000.00
Jun 30, 2026 180,000.00
Mar 31, 2026 180,000.00
Mar 31, 2026 180,000.00
Dec 31, 2025 180,000.00
Dec 31, 2025 180,000.00
Dec 31, 2025 2.15 Mn
Dec 31, 2025 2.15 Mn
Sep 30, 2025 180,000.00
Sep 30, 2025 180,000.00
Jun 30, 2025 180,000.00
Jun 30, 2025 180,000.00
Mar 31, 2025 180,000.00
Mar 31, 2025 180,000.00
Dec 31, 2024 2.51 Mn
Dec 31, 2024 180,000.00
Dec 31, 2024 2.51 Mn
Dec 31, 2024 180,000.00
Jun 30, 2024 180,000.00
Jun 30, 2024 180,000.00